Insider Trading & Ownership of Ultragenyx Pharmaceutical Inc.

Location
Novato, CA
Summary
The estimated value of insider holdings of Ultragenyx Pharmaceutical Inc. is at least $26,208,420 dollars as of 12 Aug 2021. Ultragenyx Pharmaceutical Inc. is the Director of Arcturus Therapeutics Holdings Inc. and owns shares of Arcturus Therapeutics Holdings Inc. (ARCT) stock worth about $26.21M.
Signature
/s/ Mardi C. Dier, EVP and Chief Financial Officer
All Insider Reports
All Insider Reports

Notify me when Ultragenyx Pharmaceutical Inc. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Ultragenyx Pharmaceutical Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARCT Arcturus Therapeutics Holdings Inc. Director $26,208,420 10 Aug 2021

Insider Transactions Reported by Ultragenyx Pharmaceutical Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.